AHA comments on MedPAC topics to be considered in the new cycle: the 340B Drug Pricing Program, inpatient rehabilitation facility (IRF) payments, the physician fee schedule (PFS) and telehealth.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA's comments on CMS' proposed rule to mitigate the impact of significant, anomalous and highly suspect (SAHS) billing activity within the Medicare Shared Savings Program (MSSP) in calendar year (CY) 2023.
The American Hospital Association (AHA) expresses their opposition to H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net (340B ACCESS) Act.
In CMS’s upcoming fiscal year (FY) 2025 IPPS final rule, the AHA urges CMS to maintain the uninsured rate at its proposed level of 8.7%. Doing so would provide critical stability for DSH hospitals that serve low-income, uninsured and historically marginalized populations.
The American Hospital Association (AHA) writes to the Senate to provide comment on the request for information (RFI) based on the Pay PCPs Act (S. 4338).
AHA comments to the Cybersecurity and Infrastructure Security Agency on their proposed rule to establish reporting requirements for cybersecurity incidents under the Cyber Incident Reporting for Critical Infrastructure Act.
AHA shares feedback on the Centers for Medicare & Medicaid Services’ draft guidance on the Medicare drug price negotiation program.
June 28, 2024 The Honorable Katherine TaiU.S. Trade Representative600 17th Street NWWashington, DC 20508